New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome


You May Also Like

OncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016

REDWOOD CITY, Calif., March 16, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) will ...

Arbutus Presents Corporate Update on Key Milestones

First Subject Dosed in Phase 1 Study of AB-506, Arbutus’ Second-Generation Capsid InhibitorAll-Oral Combination ...